Two Sigma Investments, LP Apellis Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 58,783 shares of APLS stock, worth $1.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

58,783

Previous 27,546 113.4%

Holding current value

$1.95 Million

Previous $1.06 Million 60.51%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$28.84 - $41.15 $900,875 - $1.29 Million	31,237 Added 113.4%	58,783 $1.7 Million
Q2 2024 Aug 14, 2024	BUY	$38.07 - $59.71 $1.05 Million - $1.64 Million	27,546 New	27,546 $1.06 Million
Q3 2022 Nov 14, 2022	BUY	$44.76 - $69.66 $5.08 Million - $7.9 Million	113,472 New	113,472 $7.75 Million
Q4 2021 Feb 14, 2022	SELL	$30.74 - $49.16 $11.1 Million - $17.8 Million	-362,204 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$31.4 - $69.84 $3.54 Million - $7.88 Million	-112,834 Reduced 23.75%	362,204 $11.9 Million
Q2 2021 Aug 16, 2021	BUY	$40.9 - $64.9 $3.69 Million - $5.86 Million	90,307 Added 23.47%	475,038 $30 Million
Q1 2021 May 17, 2021	BUY	$40.8 - $57.39 $7.34 Million - $10.3 Million	179,991 Added 87.91%	384,731 $16.5 Million
Q4 2020 Feb 16, 2021	SELL	$30.79 - $57.2 $3.27 Million - $6.08 Million	-106,240 Reduced 34.16%	204,740 $11.7 Million
Q3 2020 Nov 16, 2020	SELL	$25.89 - $33.65 $6.18 Million - $8.03 Million	-238,558 Reduced 43.41%	310,980 $9.38 Million
Q2 2020 Aug 14, 2020	BUY	$24.8 - $38.49 $2.93 Million - $4.55 Million	118,199 Added 27.4%	549,538 $17.9 Million
Q1 2020 May 15, 2020	BUY	$17.91 - $44.33 $3.84 Million - $9.51 Million	214,562 Added 98.98%	431,339 $11.6 Million
Q4 2019 Feb 14, 2020	BUY	$22.1 - $30.8 $1.58 Million - $2.2 Million	71,464 Added 49.18%	216,777 $6.64 Million
Q3 2019 Nov 14, 2019	BUY	$24.09 - $32.18 $3.5 Million - $4.68 Million	145,313 New	145,313 $3.5 Million

Others Institutions Holding APLS

# of Institutions

308

Shares Held

115M

Call Options Held

3.85M

Put Options Held

1.09M

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.64B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Apellis Pharmaceuticals, Inc. Transaction History